STOCK TITAN
  1. Home
  2. Sec-filings
  3. PAHC
  4. [Form 4] PHIBRO ANIMAL HEALTH CORP Insider Trading Activity

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BENDHEIM JACK reported acquisition or exercise transactions in this Form 4 filing.

Phibro Animal Health Corp reported that Executive Chairman and 10% owner Jack Bendheim received a grant of 12,103 restricted stock units (RSUs), each representing one share of Class A Common Stock. These RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to his continued employment. Following the award, Bendheim directly holds 26,640 Class A shares and is also reported as having shared voting and investment power over 56,152 Class A shares held by BFI Co., LLC, while disclaiming beneficial ownership beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider BENDHEIM JACK, BFI Co., LLC
Role Executive Chairman | 10% Owner
Type Security Shares Price Value
Grant/Award Class A Common Stock F1, F2, F3 12,103 $0.00 $0.00
holding Class A Common Stock F4 -- -- --
Holdings After Transaction: Class A Common Stock — 26,640 shares (Direct); Class A Common Stock — 56,152 shares (Indirect, See)
Footnotes (4)
  1. F1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
  2. F2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
  3. F3. The reported securities are directly held by Jack Bendheim.
  4. F4. The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
RSUs granted 12,103 RSUs Grant of restricted stock units representing Class A Common Stock to Jack Bendheim on 2026-08-06
Direct Class A holdings 26,640 shares Class A Common Stock directly held by Jack Bendheim following the RSU grant
Indirect Class A holdings via BFI 56,152 shares Class A Common Stock held by BFI Co., LLC over which Bendheim has voting and dispositive power
restricted stock units ("RSUs") financial
"The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
voting and dispositive power financial
"Jack Bendheim ... exercises voting and dispositive power over BFI and may be deemed to have shared"
pecuniary interest financial
"Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did PAHC Executive Chairman Jack Bendheim acquire in this Form 4 filing?
Jack Bendheim received a grant of 12,103 restricted stock units (RSUs), each representing a contingent right to one share of PAHC Class A Common Stock as equity compensation.

How do the new RSUs for PAHC’s Jack Bendheim vest over time?
The 12,103 RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, conditioned on Bendheim’s continued employment through each vesting date.

How many PAHC Class A shares does Jack Bendheim hold directly after this transaction?
After the reported RSU grant, Jack Bendheim directly holds 26,640 shares of PAHC Class A Common Stock, as stated in the post-transaction holdings in the filing.

What is BFI Co., LLC’s role in Jack Bendheim’s PAHC share ownership?
BFI Co., LLC directly holds 56,152 PAHC Class A shares. Bendheim exercises voting and dispositive power over BFI and may be deemed to share voting and investment power, but he disclaims beneficial ownership beyond his pecuniary interest.

Was this PAHC Form 4 transaction executed under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the data do not indicate that the RSU grant was executed under a pre-arranged trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BENDHEIM JACK
(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21
(Street)
TEANECK NEW JERSEY 07666
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock(1)08/06/2026A12,103(2)A$026,640D(3)
Class A Common Stock56,152ISee(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
BENDHEIM JACK
(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21
(Street)
TEANECK NEW JERSEY 07666
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
1. Name and Address of Reporting Person*
BFI Co., LLC
(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21
(Street)
TEANECK NEW JERSEY 07666
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
2. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date.
3. The reported securities are directly held by Jack Bendheim.
4. The reported securities are directly held by BFI Co., LLC ("BFI"). Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
/s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim08/10/2026
/s/ Judith Weinstein, as Attorney-in-Fact for BFI Co., LLC08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR